Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Oleg V. Knyazev"'
Autor:
Anna V. Kagramanova, Vladimir E. Tankovskiy, Aleksandra N. Demchenko, Oleg V. Knyazev, Asfold I. Parfenov
Publikováno v:
Терапевтический архив, Vol 96, Iss 2, Pp 143-146 (2024)
The article provides information on the pathogenesis, classification and frequency of ophthalmic extra-intestinal manifestations in patients with inflammatory bowel diseases (IBD). A clinical observation of a patient with autoimmune uveitis and IBD i
Externí odkaz:
https://doaj.org/article/37a7e3b0a1c94e0cb8c713bfe300e524
Publikováno v:
Терапевтический архив, Vol 95, Iss 2, Pp 193-197 (2023)
The article describes the historical milestones in the study of Crohn's disease from the time of its original description in the 17th century, the revolution in the medical community after the landmark paper in 1932, to the present day. The history o
Externí odkaz:
https://doaj.org/article/d1ee6ee5e3d9406f994e5f2192c25c47
Autor:
Oleg V. Knyazev, Anna V. Kagramanova, Nina A. Fadeeva, Irina G. Pelipas, Albina A. Lishchinskaya, Maria Iu. Zvyaglova, Asfold I. Parfenov
Publikováno v:
Consilium Medicum, Vol 24, Iss 5, Pp 287-290 (2022)
We present a clinical case of intestinal tuberculosis in a young patient with a clinical simulation of Crohn's disease. The article addresses clinical presentation, challenges of differential diagnostics of intestinal tuberculosis, and nonsurgical an
Externí odkaz:
https://doaj.org/article/7a736b2d64da481c95a1a8388f57792e
Autor:
Albina A. Lishchinskaya, Oleg V. Knyazev, Anna V. Kagramanova, Galina A. Dudina, Elena A. Sabelnikova, Irina A. Li, Karina K. Noskova, Natalia A. Bodunova, Asfold I. Parfenov
Publikováno v:
Терапевтический архив, Vol 94, Iss 2, Pp 172-179 (2022)
Background. Inflammatory bowel diseases (IBD) are characterized by chronic immune inflammation of the mucous membrane and/or the thickness of the intestinal wall, and are also accompanied by disorders of the blood clotting system and the development
Externí odkaz:
https://doaj.org/article/94898a615b6c40caa432237c1ee09ad1
Autor:
Oleg V. Knyazev, Sergey G. Khomeriki, Anna V. Kagramanova, Albina A. Lishchinskaya, Olga A. Smirnova, Karina K. Noskova, Asfold I. Parfenov
Publikováno v:
Терапевтический архив, Vol 93, Iss 12, Pp 1435-1442 (2021)
Aim. To conduct comparative analysis of histological remission in patients with moderate and severe ulcerative colitis (UC), receiving biological therapy vedolizumab, mesenchymal stem cell (MSC) treatment and combined stem cells and vedolizumab thera
Externí odkaz:
https://doaj.org/article/3bbf28709c624110b510948433e92b4c
Publikováno v:
Терапевтический архив, Vol 93, Iss 12, Pp 1419-1427 (2021)
Aim. To determine factors of adherence to treatment in patients with ulcerative colitis (UC). Materials and methods. The study was performed in the department of treatment of inflammatory bowel diseases in Loginov Moscow Clinical Scientific Center
Externí odkaz:
https://doaj.org/article/78d4fd4adb9242b19afe18053290444d
Publikováno v:
Терапевтический архив, Vol 93, Iss 12, Pp 1564-1568 (2021)
The article describes the main historical milestones in the description and study of ulcerative colitis from the time of Hippocrates to the present day. The first description of the morphological picture of non-specific ulcerative colitis (NUC) was p
Externí odkaz:
https://doaj.org/article/11de846082184127901cc3ee11c92bbc
Publikováno v:
Терапевтический архив, Vol 93, Iss 8, Pp 975-981 (2021)
Current conception of deep remission in patients with ulcerative colitis (UC) consists of clinical remission, endoscopic mucosal healing and normalization of laboratory markers. Histological remission should not be used as a primary end point for the
Externí odkaz:
https://doaj.org/article/1aac92c3c4464e48b4b5acc361e254e9
Publikováno v:
Клиническая практика, Vol 12, Iss 1, Pp 53-65 (2021)
Inflammatory bowel disease (IBD) belongs to the group of diseases characterized by idiopathic inflammation of the digestive tract organs. Two basic IBD types are distinguished: ulcerative colitis and Crohns disease. The IBD symptoms including vomitin
Externí odkaz:
https://doaj.org/article/16d287a9f09644518734e234e1e231bd
Publikováno v:
Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.. 76:618-622
We investigated the efficacy of combination therapy using bone marrow-derived mesenchymal stromal cells (MSC) and Infliximab (IFX) to achieve “deep remission” in patients with luminal Crohn disease (CD). Our study included 72 patients (age 19–6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e37c457762ca9ee1f2b6b1f0305242d
https://doi.org/10.2478/prolas-2022-0095
https://doi.org/10.2478/prolas-2022-0095